Sign In
Buy CGC
$0.97
+0.0379 (+4.07%)
At Close: Aug 07, 2026
Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think
07:15am, Saturday, 08'th Aug 2026
The United States is slowly moving toward the legalization of marijuana. The next big step is the rescheduling of the drug at the federal level, which won't make it legal, just less illegal.
Canopy Growth Q1 Earnings Call Highlights
12:06pm, Friday, 07'th Aug 2026
Canopy Growth NASDAQ: CGC reported first-quarter fiscal 2027 net revenue of C$81.2 million, up 13% from the prior-year period, as the company recorded year-over-year growth across its cannabis and Sto
Canopy Growth reports fiscal first quarter revenue growth, improved margins
11:42am, Friday, 07'th Aug 2026
Canopy Growth Corporation (TSX:WEED, NYSE:CGC) reported continued revenue growth across its businesses in the first quarter of fiscal 2027, while the cannabis company narrowed its adjusted EBITDA loss
Canopy Growth Sees Steady Progress on Profitability Measures
11:14am, Friday, 07'th Aug 2026
Canopy Growth Corporation (NASDAQ:CGC) on Friday reported a first-quarter fiscal 2027 loss of two cents (three Canadian cents) per share, compared to the consensus loss of four cents (five Canadian ce
Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates
09:36am, Friday, 07'th Aug 2026
Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to a loss of $0.14 per share a year ago.
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses.
Thinking About Buying Canopy Growth? You May Want to Wait for This 1 Thing to Happen First.
10:30am, Saturday, 25'th Jul 2026
The DEA's decision on rescheduling cannabis is the next key catalyst for Canopy Growth. A decision could be forthcoming following recent government hearings.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
06:51pm, Friday, 24'th Jul 2026
Canopy Growth Corporation (CGC) reached $0.89 at the closing of the latest trading day, reflecting a -1.82% change compared to its last close.
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
08:00am, Friday, 24'th Jul 2026
Canopy Growth Corporation (âCanopy Growthâ or the âCompanyâ) (TSX: WEED) (Nasdaq: CGC) will release its financial results for the first quarter fiscal
Canopy Growth to Report First Quarter Fiscal 2027 Financial Results on August 7, 2026
07:30am, Friday, 24'th Jul 2026
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth to report Q1 2027 financial results on August 7 with a conference call at 10:00am ET.
Canopy Growth Corporation (CGC) Dips More Than Broader Market: What You Should Know
07:01pm, Wednesday, 22'nd Jul 2026
The latest trading day saw Canopy Growth Corporation (CGC) settling at $0.91, representing a -2.67% change from its previous close.
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 22'nd Jul 2026
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 Top Marijuana Stocks to Watch in July 2026
10:00am, Tuesday, 21'st Jul 2026
The cannabis industry continues evolving despite ongoing regulatory uncertainty across North America. Investors remain focused on companies with improving financial results and stronger balance sheets
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
07:30am, Tuesday, 21'st Jul 2026
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) announced it will be participating at the Canaccord Genuity Growt
President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray
05:30am, Friday, 17'th Jul 2026
Notably, the move did not affect the vastly larger market for recreational products. It also created new headaches for medical cannabis purveyors.
